Top compounds associated with response to CRK


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.067 0.05
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.081 0.05
mRNA StemRegenin 1 CTRPv2 pan-cancer AAC -0.081 0.05
mRNA paclitaxel gCSI pan-cancer AAC 0.13 0.05
mRNA OSI-906 CTRPv2 pan-cancer AAC -0.081 0.05
mRNA lovastatin CTRPv2 pan-cancer AAC 0.084 0.05
mRNA GDC-0449 GDSC1000 pan-cancer AAC 0.083 0.05
mRNA nakiterpiosin CTRPv2 pan-cancer AAC -0.075 0.05
mRNA JQ-1 CTRPv2 pan-cancer AAC -0.071 0.06
mRNA JNJ-26854165 GDSC1000 pan-cancer AAC 0.077 0.06
Download CSV